We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Protein Identified that Controls Synapse Formation

By Biotechdaily staff writers
Posted on 17 Sep 2002
A study into the molecular mechanisms responsible for controlling development of the central nervous system found that the SynCam protein plays a major role in the formation of synapses, the junctions between nerve cells through which they communicate. More...
SynCAM is a brain-specific, immunoglobulin domain-containing protein that binds to intracellular PDZ-domain proteins and functions as a homophilic cell adhesion molecule at the synapse. The study on SynCAM's role in synapse formation was published in the August 30, 2002, issue of Science.

The researchers, from the University of Texas Southwest Medical Center (Dallas, USA), identified proteins involved in synapse formation by searching the mouse genome for a candidate molecule that could form a bridge between neurons and recruit synaptic components.

They developed a model for synaptic transmission by artificially inducing synapses and performing a functional characterization using cultured neurons from laboratory mice. When SynCAM was overexpressed, a nearly three-fold increase in spontaneous synaptic structures and spontaneous synaptic activity was found. When this function of SynCAM was interrupted, the number of synapses and activity decreased.

"Until this discovery very little was known about how neurons form synapses with each other,” explained Dr. Thomas Biederer, the study's first author. "We defined how the initial contact points are being developed and from there we can figure out how the young nervous system grows into an active network.”



Related Links:
Univ. of Texas Southwest Medical Center

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Hematology Consumables
Bioblood Devices
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.